MedTrace Logo

Effects of Transcutaneous Vagus Nerve Stimulation in Chronic Pain Patients and Healthy Controls

NCT05007743 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2023-05-10

No results posted yet for this study

Summary

The tVNS-PP trial investigates the effects of transcutaneous vagus nerve stimulation (tVNS) on autonomic functions, immune responses, and disease severity in chronic pain and restless legs syndrome (RLS) patients as compared to healthy controls.

Conditions

Interventions

DEVICE

Transcutaneous vagus nerve stimulation

Frequency of 30 Hz, biphasic, rectangular pulses with a pulse width of 250 µs and an intensity of 20 mA. Device: Easy Tens+ device (body clock, London, UK)

Sponsors & Collaborators

  • University Medical Center Goettingen

    lead OTHER

Principal Investigators

  • Thomas Meyer, Prof. · University of Göttingen

  • Elisabeth Veiz, M.Sc. · University of Göttingen

  • Christoph Herrmann-Lingen, Prof. · University of Göttingen

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-21
Primary Completion
2023-08-31
Completion
2023-08-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05007743 on ClinicalTrials.gov